2022 was a year of recovery, discovery, and some losses.  While still dealing with the aftermath of COVID-19, rheumatologists were resilient as leaders for their patients and research in advancing rheumatologic care.

Many Americans think of gout as a disease from a bygone era, akin to rickets or scurvy. The condition commonly afflicted the rich and royal, including American historical figures such as Benjamin Franklin and Thomas Jefferson.

Reuters reports that in 2023, drug makers intend to increase the price of over 350 drugs. Despite public outcry and goverment attempts to limit drug price increases (Biden's Inflation Reduction Act;IRA), these increases are expected to begin in January 2023.  The IRA is suppose to allow the government's Medicare health program to negotiate prices directly for some drugs starting in 2026.